Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-01-07 @ 11:43 AM
Study NCT ID:
NCT03537157
Status:
TERMINATED
Last Update Posted:
2021-09-27
First Post:
2018-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention
Sponsor:
Alfasigma S.p.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-15
First Submit QC Date:
None
Study First Post Date:
2018-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-24
Last Update Post Date:
2021-09-27
Last Update Post Date Type:
ACTUAL